Leadership & Pay ·
NovaBridge Biosciences' board of directors approved the 2026 Omnibus Share Incentive Plan, effective July 13, 2026
IMABNovaBridge Biosciences
NovaBridge Biosciences' board of directors approved the 2026 Omnibus Share Incentive Plan, effective July 13, 2026. The plan authorizes the initial issuance of up to 11,960,000 ordinary shares (equivalent to 5,200,000 American Depositary Shares). Starting January 1, 2027, the plan allows for an annual increase equal to the lesser of 3% of outstanding shares as of the preceding December 31 or a smaller number determined by the Board. The plan is designed to attract and retain employees, consultants, and directors through options, restricted shares, share units, and cash-based awards, and will remain in effect for ten years. NovaBridge Biosciences operates in the biotechnology industry and develops therapeutic solutions.